Fortegra Announces Withdrawal of Initial Public Offering
Fortegra Announces Withdrawal of Initial Public Offering
PR Newswire
JACKSONVILLE, Fla., Feb. 7, 2024
JACKSONVILLE, Fla., Feb. 7, 2024 /PRNewswire/ -- The Fortegra Group, Inc. ("Fortegra" or the "Company"), a multinational specialty insurer and subsidiary of Tiptree Inc. (NASDAQ: TIPT), today announced that due to prevailing market conditions and the high value Tiptree Inc. ("Tiptree") and Warburg Pincus LLC ("Warburg") place on Fortegra and its growth prospects, Tiptree and Warburg have decided to withdraw the registration statement relating to the previously announced initial public offering by Fortegra. Tiptree and Warburg remain committed to supporting Fortegra as it continues to execute its growth strategy.
About Fortegra
For more than 45 years, Fortegra, via its subsidiaries, has underwritten risk management solutions that help people and businesses succeed in the face of uncertainty. As a multinational specialty insurer whose insurance subsidiaries have an A.M. Best Financial Strength Rating of A- (Excellent), we offer a diverse set of admitted and excess and surplus lines insurance products and warranty solutions.
CONTACT:
Media
Edelman Smithfield for Fortegra
fortegra@edelman.com
Investor Relations
ir@fortegra.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/fortegra-announces-withdrawal-of-initial-public-offering-302056012.html
SOURCE Fortegra
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?